Key result
Transcatheter mitral valve implantation currently faces a patient rejection rate of approximately 60% due to anatomical constraints, procedural complexity, and restriction to high-risk patients.
Population
Patients with severe mitral regurgitation considered for transcatheter mitral valve implantation (TMVI)
Design
Review
Authors
Loading...
Patient screening challenges limit TMVI availability; leaves open standardized selection criteria for future studies.
This review highlights the significant challenges in patient selection for TMVI, explaining the high rejection rate and outlining future needs for improved device design and anatomical evaluation.
Ureña et al. (2018) conducted a review in severe mitral regurgitation. Transcatheter mitral valve implantation (TMVI) was evaluated. Transcatheter mitral valve implantation currently faces a patient rejection rate of approximately 60% due to anatomical constraints, procedural complexity, and restriction to high-risk patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: